361 related articles for article (PubMed ID: 27247629)
1. Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.
Traore EJ; Wang W; Yafi FA; Hellstrom WJ
Ther Adv Urol; 2016 Jun; 8(3):192-202. PubMed ID: 27247629
[TBL] [Abstract][Full Text] [Related]
2. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Natale C; McLellan DM; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
[TBL] [Abstract][Full Text] [Related]
3. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
[TBL] [Abstract][Full Text] [Related]
5. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Gabrielson AT; Spitz JT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
[TBL] [Abstract][Full Text] [Related]
6. Collagenase Clostridium histolyticum Treatment Improves Degree of Curvature in Peyronie's Disease with Calcified Plaques.
Masterson TA; Atuluru P; Zucker I; Molina M; Ibrahim E; Nackeeran S; Kava B; Ramasamy R
Eur Urol Focus; 2023 Jan; 9(1):55-59. PubMed ID: 36272924
[TBL] [Abstract][Full Text] [Related]
7. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
8. Role of collagenase clostridium histolyticum in Peyronie's disease.
Peak TC; Mitchell GC; Yafi FA; Hellstrom WJ
Biologics; 2015; 9():107-16. PubMed ID: 26491251
[TBL] [Abstract][Full Text] [Related]
9. Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.
Anaissie J; Powers MK; Hellstrom WJ; Yafi FA
Drugs Today (Barc); 2015 Aug; 51(8):457-68. PubMed ID: 26380384
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
[TBL] [Abstract][Full Text] [Related]
12. Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
Abdel Raheem A; Johnson M; Abdel-Raheem T; Capece M; Ralph D
Sex Med Rev; 2017 Oct; 5(4):529-535. PubMed ID: 28874327
[TBL] [Abstract][Full Text] [Related]
13. Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.
Gabrielson AT; Alzweri LM; Hellstrom WJ
World J Mens Health; 2017 Dec; 35(3):134-145. PubMed ID: 28879693
[TBL] [Abstract][Full Text] [Related]
14. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
El-Khatib FM; Towe M; Yafi FA
World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Men With Peyronie's Disease and Collagenase Clostridium Histolyticum Treatment Failure: Predictors of Surgical Intervention and Outcomes.
Bajic P; Wiggins AB; Ziegelmann MJ; Levine LA
J Sex Med; 2020 May; 17(5):1005-1011. PubMed ID: 32127330
[TBL] [Abstract][Full Text] [Related]
16. Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
Mills SA; Gelbard MK
World J Urol; 2020 Feb; 38(2):269-277. PubMed ID: 31168744
[TBL] [Abstract][Full Text] [Related]
17. Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.
Abdel Raheem A; Johnson M; Ralph D; Garaffa G
Minerva Urol Nefrol; 2018 Aug; 70(4):380-385. PubMed ID: 29761688
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Sukumar S; Pijush DB; Brandes S
J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]